Patents by Inventor Uzzi Reiss

Uzzi Reiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9610258
    Abstract: Disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or long-term inflammatory-mediated conditions in affected or at-risk subjects, and for stabilizing one or more components of the mammalian extracellular matrix. Also disclosed are pharmaceutical compositions and topical formulations thereof that include multiple, phytochemically-active, nutraceutical compounds, and that possess potent anti-inflammatory and extracellular matrix-stabilizing properties both in vitro and in vivo.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: April 4, 2017
    Assignee: MD MATRIX HEALTH LLC
    Inventors: Joseph F. McWherter, Uzzi Reiss
  • Publication number: 20160243057
    Abstract: Disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or long-term inflammatory-mediated conditions in affected or at-risk subjects, and for stabilizing one or more components of the mammalian extracellular matrix. Also disclosed are pharmaceutical compositions and topical formulations thereof that include multiple, phytochemically-active, nutraceutical compounds, and that possess potent anti-inflammatory and extracellular matrix-stabilizing properties both in vitro and in vivo.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 25, 2016
    Inventors: Joseph F. McWherter, Uzzi Reiss
  • Publication number: 20140193480
    Abstract: Disclosed are pharmaceutical compositions and topical formulations thereof that include multiple, phytochemically-active, nutraceutical compounds, and that possess potent anti-inflammatory and extracellular matrix-stabilizing properties both in vitro and in vivo. Also disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or long-term inflammatory-mediated conditions in affected or at-risk subjects, and for stabilizing one or more components of the mammalian extracellular matrix.
    Type: Application
    Filed: October 15, 2013
    Publication date: July 10, 2014
    Applicant: MD MATRIX HEALTH LLC DBA MD MATRIX HEALTH INC.
    Inventors: Joseph F. McWherter, Uzzi Reiss